ATS Business Model and Strategic M&A Impact

Strategically Positioned in Large Attractive Markets 2 Levered to Positive Secular Trends Life Sciences F23 Revenues (C$ mm) Focus Areas Medical Devices Pharmaceuticals $1,210 Radiopharmaceuticals Chemicals Labor Cost Inflation Transportation EV/Hybrid $578 Automotive Aerospace Food & Beverage $371 Consumer $305 Fresh Produce Processing Sorting and Inspection Beverage Processing & Filling Warehouse Automation Personal Care Cosmetics Nuclear Energy $113 Clean Energy Total: $2,577mm De-risking of Manufacturing and Supply Chains Demand for Safety and Reliability Increasing Complexity of Automation Ecosystem Automation Supporting Transition to Electric Vehicles 6 Target growth in attractive market verticals

View entire presentation